𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Local excision and mucosal advancement for anorectal ulceration in patients infected with human immunodeficiency virus

✍ Scribed by Dr. E. C. J. Consten; J. F. M. Slors; S. A. Danner; G. J. A. Offerhaus; J. F. W. M. Bartelsman; J. J. B. Van Lanschot


Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
470 KB
Volume
82
Category
Article
ISSN
0007-1323

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

In patients infected with human immunodeficiency virus (HIV) no effective surgical procedure has been described for anorectal ulceration that is resistant to medical thearpy. This study was designed to determine the effectiveness of surgical excision of anorectal ulcers, with or without mucosal advancement. The medical records of patients with HIV and anorectal pathology diagnosed between 1984 and 1994 were reviewed. Patients with anorectal ulcers were divided into group A which was treated only with excision and group B in which excision was combined with mucosal advancement. Surgical treatment was considered successful if relief of symptoms was achieved within 4 weeks of the operation. Excision of anorectal ulcers was successful in seven of 16 patients (44 per cent) in group A. Relief of symptoms was achieved in 12 of 13 patients (92 per cent) in group B when surgical excision was combined with mucosal advancement, which is significantly better than the results in group A (P = 0.02). This non-randomized study indicates that after unsuccessful medical treatment persistent symptomatic ulcers should be treated operatively by excision with mucosal advancement.


📜 SIMILAR VOLUMES


Anal ulcer and chronic diarrhoea as mani
✍ JoséA. Pérez-Molina; Jesús Fortún; Rogelio López-Vélez 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 290 KB

Induction of alpha/beta interferon and dependent nitric oxide synthesis during Chlamydia trachomatis infection of Mc-Coy cells in the absence of exogenous cytokines. Infection and Immunity, 64,3951-3956.

CD4+ T-lymphocyte variations in patients
✍ Jeannette Guarner; Patricia Montoya; Carlos del Rio; Griselda Hernandez-Tepichin 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 34 KB

## Variability in CD4 1 T-lymphocyte measurements has been described for both normal and human immunodeficiency virus (HIV)-infected persons. Clinical protocols use CD4 1 cell counts as surrogate markers for disease progression or response. In this study, we determined the variability of CD4 1 T-l

Intensive sequential chemotherapy with h
✍ Régis T. Costello; Hacène Zerazhi; Aude Charbonnier; Jean-Marc Schiano de Colell 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB 👁 1 views

## Abstract ## BACKGROUND Optimal treatment of human immunodeficiency virus (HIV)‐associated non‐Hodgkin lymphoma (NHL) has yet to be defined, because chemotherapy could exacerbate immunodeficiency, with subsequent adverse effects for patients. ## METHODS The authors investigated the feasibility

The model for end-stage liver disease sc
✍ Javier Murillas; Antonio Rimola; Montserrat Laguno; Elisa de Lazzari; Javier Ras 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB 👁 1 views

End-stage liver disease (ESLD) has become the main cause of mortality in patients coinfected by human immunodeficiency virus (HIV) and hepatitis B virus or hepatitis C virus in developed countries. The aim of this study was to describe the natural history of and prognostic factors for ESLD, with par